Description The long-term goal of our research is to understand how molecular interactions between lipoproteins and cell surface receptors affect lipid metabolism and disease susceptibility. Knowledge of the metabolic roles of apolipoprotein (apo) E and low-density lipoprotein receptor (LDLR) family members will be combined with available structural information in the design of an experimental strategy to dissect determinants of a productive binding interaction. A novel strategy, termed expressed protein ligation, will be employed to introduce stable isotopes into a specific, predetermined, region of apoE that is essential for LDLR binding. The research to be pursued includes three specific aims. 1) Segmental isotope labeled apoE3-N-temrinal domain, in complex with lipid, will be analyzed by multidimensional heteronuclear NMR spectroscopy in experiments designed to distinguish between alternate structural models of the lipid-bound apoE. 2) The contact sites between apoE and the LDLR will be characterized. It is hypothesized that analysis of segmental isotope labeled apoE3-NT7DMPC in complex with a functional LDLR mini-receptor will yield molecular details of their binding interaction. 3) The interaction of apoE with LDL receptor related protein 6 (LRP6) will be studied. The hypothesis that LDL-A repeats located near the transmembrane spanning sequence of LRP6 are involved in apoE ligand binding will be evaluated. In addition, the postulate that a mutation in LRP6 (R611C), associated with coronary artery disease in human subjects, causes a defect in pH dependent apoE ligand release will be tested. The results of these experiments will extend knowledge of the LDLR family, apoE-mediated lipoprotein metabolism and regulation of plasma lipid homeostasis. Based on the fact that aberrations in the LDLR pathway are positively correlated to onset of cardiovascular disease and apoE manifests isoform-specific susceptibility to neurodegenerative diseases, we anticipate that new knowledge gained from these studies will provide insight into molecular mechanisms that regulate key metabolic processes in health and disease.
Apolipoprotein (apo) E is an important modulator of whole body lipid homeostasis. Biological functions of apoE are manifest through interactions with a family of cell surface receptors. Proposed research will characterize the receptor-active structure of apoE as well as its binding interaction with two members of the low-density lipoprotein receptor family. Results obtained will improve understanding of how apoE regulates lipid metabolism and its association with disease susceptibility.
|Lalefar, Nahal R; Witkowski, Andrzej; Simonsen, Jens B et al. (2016) Wnt3a nanodisks promote ex vivo expansion of hematopoietic stem and progenitor cells. J Nanobiotechnology 14:66|
|Forte, Trudy M; Ryan, Robert O (2015) Apolipoprotein A5: Extracellular and Intracellular Roles in Triglyceride Metabolism. Curr Drug Targets 16:1274-80|
|Witkowski, Andrzej; Krishnamoorthy, Aparna; Su, Betty et al. (2015) Isolation and characterization of recombinant murine Wnt3a. Protein Expr Purif 106:41-8|
|Crosby, Natasha M; Ghosh, Mistuni; Su, Betty et al. (2015) Anti-CD20 single chain variable antibody fragment-apolipoprotein A-I chimera containing nanodisks promote targeted bioactive agent delivery to CD20-positive lymphomas. Biochem Cell Biol 93:343-50|
|Ikon, Nikita; Su, Betty; Hsu, Fong-Fu et al. (2015) Exogenous cardiolipin localizes to mitochondria and prevents TAZ knockdown-induced apoptosis in myeloid progenitor cells. Biochem Biophys Res Commun 464:580-5|
|Forte, Trudy M; Sharma, Vineeta; Ryan, Robert O (2015) Apolipoprotein A-V gene therapy for disease prevention / treatment: a critical analysis. J Biomed Res 30:|
|Ryan, Robert O (2015) Metabolic annotation of 2-ethylhydracrylic acid. Clin Chim Acta 448:91-7|
|Ghosh, Mistuni; Ren, Gang; Simonsen, Jens B et al. (2014) Cationic lipid nanodisks as an siRNA delivery vehicle. Biochem Cell Biol 92:200-5|
|Ghosh, Mistuni; Ryan, Robert O (2014) Curcumin homing to the nucleolus: mechanism for initiation of an apoptotic program. J Nutr Biochem 25:1117-23|
|Su, Betty; Ryan, Robert O (2014) Metabolic biology of 3-methylglutaconic acid-uria: a new perspective. J Inherit Metab Dis 37:359-68|
Showing the most recent 10 out of 24 publications